Annual Current Liabilities
$2.63 M
+$756.40 K+40.29%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual total current liabilities is $2.63 million, with the most recent change of +$756.40 thousand (+40.29%) on December 31, 2023.
- During the last 3 years, KTTA annual current liabilities has risen by +$2.63 million (+39809.09%).
- KTTA annual current liabilities is now at all-time high.
Performance
KTTA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$660.40 K
-$734.50 K-52.66%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly total current liabilities is $660.40 thousand, with the most recent change of -$734.50 thousand (-52.66%) on September 30, 2024.
- Over the past year, KTTA quarterly current liabilities has dropped by -$734.50 thousand (-52.66%).
- KTTA quarterly current liabilities is now -74.93% below its all-time high of $2.63 million, reached on December 31, 2023.
Performance
KTTA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
KTTA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.3% | -52.7% |
| 3 y3 years | +10000.0% | -56.4% |
| 5 y5 years | +10000.0% | -56.4% |
KTTA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +488.9% | -74.9% | +52.3% |
| 5 y | 5-year | at high | >+9999.0% | -74.9% | +175.7% |
| alltime | all time | at high | >+9999.0% | -74.9% | +175.7% |
Pasithea Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $660.40 K(-52.7%) |
| Jun 2024 | - | $1.39 M(-43.5%) |
| Mar 2024 | - | $2.47 M(-6.3%) |
| Dec 2023 | $2.63 M(+40.3%) | $2.63 M(+28.9%) |
| Sep 2023 | - | $2.04 M(-8.3%) |
| Jun 2023 | - | $2.23 M(+5.0%) |
| Mar 2023 | - | $2.12 M(+13.0%) |
| Dec 2022 | $1.88 M | $1.88 M(+24.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.51 M(+59.4%) |
| Jun 2022 | - | $950.10 K(+119.1%) |
| Mar 2022 | - | $433.70 K(-3.0%) |
| Dec 2021 | $447.30 K(+6677.3%) | $447.30 K(-15.3%) |
| Sep 2021 | - | $528.10 K(+16.1%) |
| Jun 2021 | - | $454.70 K(+89.9%) |
| Mar 2021 | - | $239.50 K |
| Dec 2020 | $6600.00 | - |
FAQ
- What is Pasithea Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual current liabilities year-on-year change?
- What is Pasithea Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly current liabilities year-on-year change?
What is Pasithea Therapeutics annual total current liabilities?
The current annual current liabilities of KTTA is $2.63 M
What is the all time high annual current liabilities for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual total current liabilities is $2.63 M
What is Pasithea Therapeutics annual current liabilities year-on-year change?
Over the past year, KTTA annual total current liabilities has changed by +$756.40 K (+40.29%)
What is Pasithea Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of KTTA is $660.40 K
What is the all time high quarterly current liabilities for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly total current liabilities is $2.63 M
What is Pasithea Therapeutics quarterly current liabilities year-on-year change?
Over the past year, KTTA quarterly total current liabilities has changed by -$734.50 K (-52.66%)